DOCSLIB.ORG

Structural Studies of Terpenoid Biosynthesis And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Structural Studies of Terpenoid Biosynthesis And STRUCTURAL STUDIES OF TERPENOID BIOSYNTHESIS AND BACTERIAL CELL DIVISION A Dissertation by DONG YANG Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY August 2006 Major Subject: Biochemistry STRUCTURAL STUDIES OF TERPENOID BIOSYNTHESIS AND BACTERIAL CELL DIVISION A Dissertation by DONG YANG Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Approved by: Chair of Committee, James C. Sacchettini Committee Members, James C. Hu Patricia J. Liwang Terry L. Thomas Head of Department, Gregory D. Reinhart August 2006 Major Subject: Biochemistry iii ABSTRACT Structural Studies of Terpenoid Biosynthesis and Bacterial Cell Division. (August 2006) Dong Yang, B.S., Zhe Jiang University Chair of Advisory Committee: Dr. James C. Sacchettini The objective of this work is to investigate the structures of two nucleotide binding proteins: mevalonate kinase (MVK) and FtsZ. MVK is the key enzyme involved in terpenoid biosynthesis. In this study, we solved the crystal structures of the M. jannaschii MVK apoprotein, as well as the protein in complex with ligands. Its fold was analyzed and firmly established within the GHMP kinase family, in which homoserine kinase (HSK), phosphomevalonate kinase and galactokinase also belong. Structural analysis in combination with enzyme kinetics studies revealed the mechanism of this enzyme upon substrate binding, catalysis and inhibition. In particular, the phosphate-binding loop was found to be critically involved in the binding of nucleotides and terpenoids, via the interaction with a di-phosphate moiety from the ligand. An enzymatic reaction mechanism was constructed based on our structural data and it is consistent with kinetics studies from the literature. In this mechanism, the invariant residue Asp 155 functions as a general base that increases the nucleophilicity of the phosphoryl acceptor. Finally, a virtual screening study has been iv performed to explore the ligand binding potential of MVK. Compounds predicted to bind MVK were tested and analyzed. FtsZ is a prokaryotic homologue of tubulin that forms the apparatus for bacterial cell division. The structure of a crystal filament of the M. tuberculosis FtsZ complexed with GDP was described in this study. It shows an anti-parallel, left-handed double helical architecture. Compared with the straight crystal filament revealed earlier by other groups, the catalytic T7 loop in our structure is found to be outside the nucleotide binding site, indicating the GTPase is inactive. Furthermore, the buried surface area in our crystal filament is less, probably suggesting the helical FtsZ filament is less stable. We therefore proposed that the hydrolysis of GTP and the releasing of the γ-phosphate group will trigger the rearrangement of the FtsZ fibler, characterized by the exclusion of the T7 loop, which might lead to a less stable helical filament and would be the first step for the disassembly of FtsZ polymer. v DEDICATION To my parents and sister, for their love and support. To my friends for their help and encouragement. vi ACKNOWLEDGEMENTS First of all, I am thankful to Dr. James Sacchettini, my advisor, for giving me opportunities to do research in his lab and also giving me valuable advice and guidance during these years. I am also thankful to other members of my advisory committee: Dr. Patricia Liwang, Dr. James Hu and Dr. Terry Thomas, for their suggestions and discussion on my work. Second, I have to thank colleagues in Dr. Sacchettini’s lab, particularly Dr. Lance Shipman, as he led me into the world of crystallography when I just finished my rotation and joined this lab. I thank other members or former members in our group, particularly Dr. Remo Perozzo, Dr. Christoph Eicken, Dr. Sheng Ye, Dr. Clare Smith, Dr. Chih-chin Huang, Dr. Yoonsang Cho, Dr. Sudharsan Sridharan, Ms. Stephanie Swanson, Ms. Arati Ramesh and Mr. Feng Wang, for their advice and help at various stages during my work. My research also involves several collaborators. Particularly, I have to thank Dr. David Borhani (Abbott Bioresearch Center) and Ms. E. Lucile White (Southern Research Institute), for their initial work on FtsZ and their generosity in supplying me full-length FtsZ proteins. I have to thank Mr. Christos Savva for his kind help in performing EM studies on FtsZ filaments. I am also thankful to Drs. A. Ian Scott and Charles Roessner for providing us initial clones of MVK. Finally, my work could not be completed without help from the supporting staff in this department, particularly the administrative assistants for Dr. Sacchettni: Ms. Karen Hodges and the late Dr. Linda Fisher. vii NOMENCLATURE ADP Adenosine 5’-diphosphate ADPβS Adenosine 5’-(βthiol)-diphosphate AMP Adenosine 5’-monophosphate AMPPCP Adenosine 5’-(β, γ-methylene)-diphosphate APS Advanced Photon Source ATP Adenosine 5’-triphosphate CAMD Center for Advanced Microstructures and Devices CDP Cytidine 5’-diphosphate CDP-ME 4-diphosphocytidyl-2-C-methyl-erythritol CDP-ME2P 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate CMP Cytidine 5’-monophosphate CoA Coenzyme A CTP Cytidine 5’-triphosphate DEAE Diethylaminoethyl DMAPP Dimethylallylpyrophosphate DMSO Dimethyl Sulfoxide DTT Dithiothreitol dUTP 2'-deoxyuridine 5'-triphosphate DXP 1-Deoxy-D-xylulose 5-phosphate EM Electron Microscopy FPP Farnesyl Pyrophosphate viii GAP GTPase Activating Protein GDP Guanosine 5’-diphosphate GDPβS Guanosine 5’-(βthiol)-diphosphate GGPP Geranylgeranyl Diphosphate GMPPCP Guanosine 5'-(β, γ-methylene)-diphosphonate GMPPNP Guanosine 5’-(β, γ-imido)-triphosphate GPP Geranyl Pyrophosphate GTP Guanosine 5’-triphosphate GTPγS Guanosine 5'-(3-O-thio)triphosphate HEPES N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulfonic Acid HIDS Hyperimmunoglobulinemia D Syndrome HMB-PP (E)-4-hydroxy-3-methyl-but-2-enylpyrophosphate HMG 3-Hydroxy-3-methyl glutaryl HSK Homoserine Kinase IPP Isopentenyl Pyrophosphate IPTG Isopropyl-beta-D-thiogalactopyranoside ITP Inosine 5’-triphosphate LB Luria Bertani Broth LDH Lactate Dehydrogenase LDL Low Density Lipoprotein MAD Multiwavelength Anomalous Dispersion MECDP 2-C-methyl-D-erythritol 2,4-cyclodiphosphate ix MEP Methylerythritol Phosphate MIR Multiple Isomorphous Replacement MPD 2-methyl-2,4-pentanediol MVK Mevalonate Kinase NAD+ Nicotinamide Adenine Dinucleotide (oxidized form) NADH Nicotinamide Adenine Dinucleotide (reduced form) NADPH Nicotinamide Adenine Dinucleotide Phosphate (reduced form) NCS Non-crystallography symmetry NDP Any Diphosphonucleotide PAGE Polyacrylamide Gel Electrophoresis PCR Polymerase Chain Reaction PIP Di-iodobis-ethylenediamine-diplatinum II nitrate PK Pyruvate Kinase PMSF Phenylmethylsulfonyl Fluoride RGS Regulators of G Protein Signaling SAD Singlewavelength Anomalous Dispersion SIR Single Isomorphous Replacement SDS Sodium dodecyl sulphate Se-Met Selenium Methionine SRE Sterol Regulatory Element Tris Tris(hydroxymethyl) Aminomethene UPPS Undecaprenyl Pyrophosphate Synthetase x UTP Uridine 5’-triphosphate X Any Amino Acid Residue xi TABLE OF CONTENTS Page ABSTRACT ……………………………………………………………………………iii DEDICATION ………………………………………………………………………….v ACKNOWLEDGEMENTS……………………………….……………………………vi NOMENCLATURE……………………………………………………………………vii TABLE OF CONTENTS……………………………………………………………….xi LIST OF FIGURES……………………………………………………………………xiii LIST OF TABLES……………………………………………………………………..xvi CHAPTER I INTRODUCTION TO STRUCTURAL BIOLOGY …………………....….1 Scope of Structural Biology…………………….…………………….....1 Introduction to Crystallography ...………..……………..……..………..5 Theory of Structural Based Drug Design ...…….………...…………...20 Overview of Chapters ……….………...………….……...……………24 II BACKGROUND OF TERPENOID BIOSYNTHESIS AND MVK……....27 Terpenoid Biosynthesis ……..……..…………………………….…....27 MVK…………………………………………..……......………….…..41 Significance of This Work………………………...…………………...47 III STRUCTURAL STUDY OF MVK………………………………………48 Methods ……………..….…...………………………………………...48 Results and Discussion……………………...…………………….…...56 Conclusion……………………………………………………………113 xii CHAPTER Page IV BACKGROUND OF CELL DIVISION AND FTSZ…………....……...116 Bacterial Cell Division ..……..……………………………….….….116 FtsZ ……..………………..……………………………………….....117 Significance of This Work…………………………………………...126 V STRUCTURAL STUDY OF A FTSZ CRYSTAL PROTOFILAMENT.128 Methods ……………………………………………..………………128 Results and Discussion ……………………………………….……..133 Conclusion …………………………………………………………..157 VI GENERAL CONCLUSION AND FUTURE DIRECTIONS …………158 REFERENCES………………………………………..….…..………………………..163 VITA…………………………………………………………………………………...175 xiii LIST OF FIGURES FIGURE Page 1. Basics of Diffraction.……….………………………………………………..……..8 2. Principle of MAD………………………….………..………………………….....12 3. Principle of Molecular Replacement……………..……………………………….14 4. The Mevalonate Dependent Pathway for IPP Biosynthesis….………………...…33 5. The Non-mevalonate Pathway for IPP Biosynthesis…………..……..…………..36 6. Prenyltransferase………………………………………………………………….38 7. The Reaction Mechanism of MVK……………………………………………….42 8. Multiple Sequence Alignment of MVKs from Various Sources…………….……58 9. Anomalous Patterson Map………………………………………………….…….62 10. The Electron Density Maps before and after Density Modification……....….…64 11. Rat and M. jannaschii MVK…………………………………………….………66 12. Ramachandran Plot of MVK Crystal Structure…………………..…….……….68 13. Fold Comparison of N-domains of GHMP Kinases……………….……………70 14. Fold Comparison of C-domains of GHMP Kinases……………….……………71
Load more

Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • Non-Homologous Isofunctional Enzymes: a Systematic Analysis Of
    Omelchenko et al. Biology Direct 2010, 5:31 http://www.biology-direct.com/content/5/1/31 RESEARCH Open Access Non-homologousResearch isofunctional enzymes: A systematic analysis of alternative solutions in enzyme evolution Marina V Omelchenko, Michael Y Galperin*, Yuri I Wolf and Eugene V Koonin Abstract Background: Evolutionarily unrelated proteins that catalyze the same biochemical reactions are often referred to as analogous - as opposed to homologous - enzymes. The existence of numerous alternative, non-homologous enzyme isoforms presents an interesting evolutionary problem; it also complicates genome-based reconstruction of the metabolic pathways in a variety of organisms. In 1998, a systematic search for analogous enzymes resulted in the identification of 105 Enzyme Commission (EC) numbers that included two or more proteins without detectable sequence similarity to each other, including 34 EC nodes where proteins were known (or predicted) to have distinct structural folds, indicating independent evolutionary origins. In the past 12 years, many putative non-homologous isofunctional enzymes were identified in newly sequenced genomes. In addition, efforts in structural genomics resulted in a vastly improved structural coverage of proteomes, providing for definitive assessment of (non)homologous relationships between proteins. Results: We report the results of a comprehensive search for non-homologous isofunctional enzymes (NISE) that yielded 185 EC nodes with two or more experimentally characterized - or predicted - structurally unrelated proteins. Of these NISE sets, only 74 were from the original 1998 list. Structural assignments of the NISE show over-representation of proteins with the TIM barrel fold and the nucleotide-binding Rossmann fold. From the functional perspective, the set of NISE is enriched in hydrolases, particularly carbohydrate hydrolases, and in enzymes involved in defense against oxidative stress.
    [Show full text]
  • In Vitro and in Vivo Models Analyzing Von Hippel-Lindau Disease-Specific Mutations
    [CANCER RESEARCH 64, 8595–8603, December 1, 2004] In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations W. Kimryn Rathmell,1,3 Michele M. Hickey,1,2 Natalie A. Bezman,1 Christie A. Chmielecki,3 Natalie C. Carraway,3 and M. Celeste Simon1,2 1Abramson Family Cancer Research Institute and the Department of Cell and Molecular Biology, and 2Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, Pennsylvania; and 3Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina ABSTRACT transport and droplet formation (8, 9). Unregulated expression of the full complement of hypoxia response genes is surmised to contribute Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene much of the clinical and pathological phenotype of renal cell carci- cause tissue-specific tumors, with a striking genotype-phenotype correla- noma, which is characterized as a highly vascular, glycolytic, lipid- tion. Loss of VHL expression predisposes to hemangioblastoma and clear cell renal cell carcinoma, whereas specific point mutations predispose to rich tumor that can be associated with polycythemia (10, 11). Detailed pheochromocytoma, polycythemia, or combinations of hemangioblas- studies of the effects of VHL loss have identified the regulation of the toma, renal cell carcinoma, and/or pheochromocytoma. The VHL protein hypoxia response pathway via the proteasomal degradation of HIF1␣ (pVHL) has been implicated in many cellular activities including the and HIF2␣ as a major activity of the VHL protein (pVHL; refs. hypoxia response, cell cycle arrest, apoptosis, and extracellular matrix 12–15). The pVHL acts as the substrate receptor for an E3 ubiquitin Ϫ Ϫ remodeling.
    [Show full text]
  • The Incretin Receptors for GLP-1 and GIP Are Essential for the Sustained Metabolic Actions of Vildagliptin in Mice
    Diabetes Publish Ahead of Print, published online August 29, 2007 The incretin receptors for GLP-1 and GIP are essential for the sustained metabolic actions of vildagliptin in mice Grace Flock, Laurie L. Baggio, Christine Longuet and Daniel J. Drucker The Samuel Lunenfeld Research Institute, Department of Medicine, Mount Sinai Hospital and the Banting and Best Diabetes Center, University of Toronto, Toronto, Canada. Running title: Incretin receptors and mechanisms of DPP-4 action Address correspondence to: Dr. Daniel J. Drucker Mount Sinai Hospital SLRI Room 975C 600 University Avenue Toronto Ontario M5G 1X5 Received for publication 22 May 2007 and accepted in revised form 20 August 2007. Additional information can be found in an online appendix at http://diabetes.diabetesjournls.org. Copyright American Diabetes Association, Inc., 2007 Incretin receptors and mechanisms of DPP-4 action Abstract Objective: DPP4 inhibitors (DPP-4i) lower blood glucose in diabetic subjects however the mechanism of action through which these agents improve glucose homeostasis remains incompletely understood. Although GLP-1 and GIP represent important targets for DPP4 activity, whether additional substrates are important for the glucose-lowering actions of DPP4 inhibitors remains uncertain. Research Design and Methods: We examined the efficacy of continuous vildagliptin administration in wildtype (WT) and dual incretin receptor knockout (DIRKO) mice after 8 weeks of a high fat (HF)-diet. Results: Vildagliptin had no significant effect on food intake, energy expenditure, body composition, body weight gain or insulin sensitivity in WT or DIRKO mice. However glycemic excursion after oral glucose challenge was significantly reduced in WT but not in DIRKO mice after vildagliptin treatment.
    [Show full text]
  • The Mechanism of GHMP Kinases by QM/MM Studies
    The Role of Arg228 in the phosphorylation of galactokinase: The mechanism of GHMP kinases by QM/MM studies Huang, M., Li, X., Zou, J-W., & Timson, D. J. (2013). The Role of Arg228 in the phosphorylation of galactokinase: The mechanism of GHMP kinases by QM/MM studies. Biochemistry, 52(28), 4858. https://doi.org/10.1021/bi400228e Published in: Biochemistry Document Version: Early version, also known as pre-print Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:01. Oct. 2021 Article pubs.acs.org/biochemistry Role of Arg228 in the Phosphorylation of Galactokinase: The Mechanism of GHMP Kinases by Quantum Mechanics/Molecular Mechanics Studies † † ‡ § Meilan Huang,*, Xiaozhou Li, Jian-Wei Zou, and David J. Timson † School of Chemistry and Chemical Engineering, Queen’s University Belfast, David Keir Building, Stranmillis Road, Belfast BT9 5AG, U.K.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • The Role of the Salvage Pathway in Nucleotide Sugar Biosynthesis
    THE ROLE OF THE SALVAGE PATHWAY IN NUCLEOTIDE SUGAR BIOSYNTHESIS: IDENTIFICATION OF SUGAR KINASES AND NDP-SUGAR PYROPHOSPHORYLASES by TING YANG (Under the Direction of Maor Bar-Peled) ABSTRACT The synthesis of polysaccharides, glycoproteins, glycolipids, glycosylated secondary metabolites and hormones requires a large number of glycosyltransferases and a constant supply of nucleotide sugars. In plants, photosynthesis and the NDP-sugar inter-conversion pathway are the major entry points to form NDP-sugars. In addition to these pathways is the salvage pathway, a less understood metabolism that provides the flux of NDP-sugars. This latter pathway involves the hydrolysis of glycans to free sugars, sugar transport, sugar phosphorylation and nucleotidylation. The balance between glycan synthesis and recycling as well as its regulation at various plant developmental stages remains elusive as many of the molecular components are unknown. To understand how the salvage pathway contributes to the sugar flux and cell wall biosynthesis, my research focused on the functional identification of salvage pathway sugar kinases and NDP-sugar pyrophosphorylases. This research led to the first identification and enzymatic characterization of galacturonic acid kinase (GalA kinase), galactokinase (GalK), a broad UDP-sugar pyrophosphorylase (sloppy), two promiscuous UDP-GlcNAc pyrophosphorylases (GlcNAc-1-P uridylyltransferases), as well as UDP-sugar pyrophosphorylase paralogs from Trypanosoma cruzi and Leishmania major. To evaluate the salvage pathway in plant biology, we further investigated a sugar kinase mutant: galacturonic acid kinase mutant (galak) and determined if and how galak KO mutant affects the synthesis of glycans in Arabidopsis. Feeding galacturonic acid to the seedlings exhibited a 40-fold accumulation of free GalA in galak mutant, while the wild type (WT) plant readily metabolizes the fed-sugar.
    [Show full text]
  • Gain-Of-Function Effects of Mutant P53 Explored Using a Three
    Gain-of-Function Effects of Mutant p53 Explored Using a Three- Dimensional Culture Model of Breast Cancer William A. Freed-Pastor Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2012 © 2011 William A. Freed-Pastor All Rights Reserved ABSTRACT Gain-of-Function Effects of Mutant p53 Explored Using a Three-Dimensional Culture Model of Breast Cancer William A. Freed-Pastor p53 is the most frequent target for mutation in human tumors and mutation at this locus is a common and early event in breast carcinogenesis. Breast tumors with mutated p53 often contain abundant levels of this mutant protein, which has been postulated to actively contribute to tumorigenesis by acquiring pro-oncogenic (“gain- of-function”) properties. To elucidate how mutant p53 might contribute to mammary carcinogenesis, we employed a three-dimensional (3D) culture model of breast cancer. When placed in a laminin-rich extracellular matrix, non-malignant mammary epithelial cells form structures highly reminiscent for many aspects of acinar structures found in vivo. On the other hand, breast cancer cells, when placed in the same environment, form highly disorganized and sometimes invasive structures. Modulation of critical oncogenic signaling pathways has been shown to phenotypically revert breast cancer cells to a more acinar-like morphology. We examined the role of mutant p53 in this context by generating stable, regulatable p53 shRNA derivatives of mammary carcinoma cell lines to deplete endogenous mutant p53. We demonstrated that, depending on the cellular context, mutant p53 depletion is sufficient to significantly reduce invasion or in some cases actually induce a phenotypic reversion to more acinar-like structures in breast cancer cells grown in 3D culture.
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • Imperial Life Sciences
    PRICE LIST 2020/21 Genomics Reagents & Consumables Cell & Imaging Advanced Molecular Diagnostics Imperial Life Sciences One Company Complete Solutions + 91 124 4559 800 - 99 [email protected] Imperial life Sciences (P) Ltd Price list 2020-21 (consumables) M/S NEW ENGLAND BIOLABS INC U Price Rs. (2020- Part No Description - without units Unit Size 21) E6442L NEBNext Multiplex Oligos for Illumina (96 Unique Dual Index Primer Pairs) Set 2 384 rxns 2,47,940.00 E6442S NEBNext Multiplex Oligos for Illumina (96 Unique Dual Index Primer Pairs) Set 2 96 rxns 68,908.00 E7850L NEBNext rRNA Depletion Kit (Bacteria) 24 rxns 1,39,104.00 E7850S NEBNext rRNA Depletion Kit (Bacteria) 6 rxns 38,254.00 E7850X NEBNext rRNA Depletion Kit (Bacteria) 96 rxns 5,00,388.00 E7860L NEBNext rRNA Depletion Kit (Bacteria) with RNA Sample Purification Beads 24 rxns 1,44,900.00 E7860S NEBNext rRNA Depletion Kit (Bacteria) with RNA Sample Purification Beads 6 rxns 39,284.00 E7860X NEBNext rRNA Depletion Kit (Bacteria) with RNA Sample Purification Beads 96 rxns 5,21,640.00 M0460T T7 RNA Polymerase (High Concentration) 50,000 units 72,643.00 M0467S Salt-T4 DNA Ligase 20,000 units 8,243.00 M0467L Salt-T4 DNA Ligase 100,000 units 32,973.00 M0470T Hi-T7 RNA Polymerase (High Concentration) 50,000 units 87,584.00 M2622L Hi-T4 DNA Ligase 100,000 units 32,973.00 M2622S Hi-T4 DNA Ligase 20,000 units 8,243.00 R0739L BsmBI-v2 1,000 units 38,254.00 R0739S BsmBI-v2 200 units 9,402.00 B0201S T4 Polynucleotide Kinase Reaction Buffer 4.0 ml 3,091.00 B0202S T4 DNA Ligase Reaction Buffer
    [Show full text]
  • Saccharomyces Cerevisiae Aspartate Kinase Mechanism and Inhibition
    In compliance with the Canadian Privacy Legislation some supporting forms may have been removed from this dissertation. While these forms may be included in the document page count, their removal does not represent any loss of content from the dissertation. Ph.D. Thesis - D. Bareich McMaster University - Department of Biochemistry FUNGAL ASPARTATE KINASE MECHANISM AND INHIBITION By DAVID C. BAREICH, B.Sc. A Thesis Submitted to the School of Graduate Studies in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy McMaster University © Copyright by David C. Bareich, June 2003 1 Ph.D. Thesis - D. Bareich McMaster University - Department of Biochemistry FUNGAL ASPARTATE KINASE MECHANISM AND INHIBITION Ph.D. Thesis - D. Bareich McMaster University - Department of Biochemistry DOCTOR OF PHILOSOPHY (2003) McMaster University (Biochemistry) Hamilton, Ontario TITLE: Saccharomyces cerevisiae aspartate kinase mechanism and inhibition AUTHOR: David Christopher Bareich B.Sc. (University of Waterloo) SUPERVISOR: Professor Gerard D. Wright NUMBER OF PAGES: xix, 181 11 Ph.D. Thesis - D. Bareich McMaster University - Department of Biochemistry ABSTRACT Aspartate kinase (AK) from Saccharomyces cerevisiae (AKsc) catalyzes the first step in the aspartate pathway responsible for biosynthesis of L-threonine, L-isoleucine, and L-methionine in fungi. Little was known about amino acids important for AKsc substrate binding and catalysis. Hypotheses about important amino acids were tested using site directed mutagenesis to substitute these amino acids with others having different properties. Steady state kinetic parameters and pH titrations of the variant enzymes showed AKsc-K18 and H292 to be important for binding and catalysis. Little was known about how the S. cerevisiae aspartate pathway kinases, AKsc and homoserine kinase (HSKsc), catalyze the transfer of the y-phosphate from adenosine triphosphate (ATP) to L-aspartate or L-homoserine, respectively.
    [Show full text]
  • Artificial Human Telomeres from DNA Nanocircle Templates
    Artificial human telomeres from DNA nanocircle templates Ulf M. Lindstro¨ m*, Ravi A. Chandrasekaran*, Lucian Orbai*, Sandra A. Helquist*, Gregory P. Miller*, Emin Oroudjev†, Helen G. Hansma†, and Eric T. Kool*‡ *Department of Chemistry, Stanford University, Stanford, CA 94305-5080; and †Department of Physics, University of California, Santa Barbara, CA 93106 Edited by Peter B. Dervan, California Institute of Technology, Pasadena, CA, and approved October 9, 2002 (received for review July 3, 2002) Human telomerase is a reverse-transcriptase enzyme that synthe- sizes the multikilobase repeating hexamer telomere sequence (TTAGGG)n at the ends of chromosomes. Here we describe a designed approach to mimicry of telomerase, in which synthetic DNA nanocircles act as essentially infinite catalytic templates for efficient synthesis of long telomeres by DNA polymerase enzymes. Results show that the combination of a nanocircle and a DNA polymerase gives a positive telomere-repeat amplification proto- col assay result for telomerase activity, and similar to the natural enzyme, it is inhibited by a known telomerase inhibitor. We show that artificial telomeres can be engineered on human chromo- somes by this approach. This strategy allows for the preparation of synthetic telomeres for biological and structural study of telomeres and proteins that interact with them, and it raises the possibility of telomere engineering in cells without expression of telomerase itself. Finally, the results provide direct physical support for a recently proposed rolling-circle mechanism for telomerase- independent telomere elongation. rolling-circle replication ͉ primer extension ͉ telomerase ͉ TRAP assay he telomerase enzyme synthesizes the multikilobase repeat- Ting hexamer telomere sequence (TTAGGG)n at the ends of chromosomes (1–3).
    [Show full text]